Glaucoma

Glaucoma is a group of eye diseases that damage the optic nerve, the structure that carries visual information from the eye to the brain. Many forms progress slowly and without pain, often affecting peripheral vision first, so changes can go unnoticed until advanced. Because damage is permanent, detecting disease before significant vision loss occurs is critical to preserving long-term function.

Viewing glaucoma as a chronic condition changes the focus of care from a single treatment to ongoing risk reduction and monitoring. Early detection allows clinicians to start therapy aimed at slowing or halting progression and to establish baseline tests for future comparison. Timely intervention often preserves useful vision and quality of life over decades.

A thorough glaucoma evaluation combines several tests rather than relying on a single measurement. Clinicians examine the optic nerve, measure intraocular pressure, assess the anterior chamber angle (gonioscopy), and measure corneal thickness (pachymetry) to interpret pressure readings accurately. Visual field testing evaluates peripheral vision and detects functional loss that may accompany optic nerve damage.

Imaging tests such as optical coherence tomography (OCT) provide objective measurements of the retinal nerve fiber layer and optic nerve head. Results are interpreted together and repeated over time to distinguish normal variation from true progression. Establishing comprehensive baseline data at diagnosis improves the accuracy of future comparisons.

Optical coherence tomography produces high-resolution, cross-sectional images of the optic nerve and retinal nerve fiber layer that are sensitive to structural thinning. OCT can reveal subtle changes that may precede detectable visual field loss, making it a valuable tool for early detection and longitudinal monitoring. Because scans are quantitative and reproducible, small changes can be tracked reliably across visits.

Clinicians correlate OCT findings with visual field results and clinical examination to form a balanced view of disease status. Baseline OCT scans create a reference that allows comparison over months and years, helping to identify true progression. When structural and functional tests agree, confidence in treatment decisions increases.

The mainstay of glaucoma treatment is lowering intraocular pressure because reduced pressure slows optic nerve damage. First-line therapy most commonly involves topical medications that decrease fluid production or improve outflow; adherence and correct instillation are essential for effectiveness. Side effects and tolerability are considered when selecting agents, and clinicians adjust therapy to balance control with patient comfort.

If medications do not achieve target pressure or adherence is problematic, procedural options such as laser therapy can improve fluid outflow and lower pressure with a favorable safety profile for many patients. More invasive surgical procedures are reserved for advanced or refractory cases and aim to provide durable pressure control. Treatment choice is individualized, weighing disease severity, risks, and patient preferences.

Laser or surgical treatment is considered when medications and monitoring do not adequately control intraocular pressure or when the disease is progressing despite therapy. Minimally invasive glaucoma surgeries (often performed in conjunction with cataract surgery) and selective laser trabeculoplasty are frequently offered earlier for suitable patients because they can lower pressure with a relatively low complication rate. Clinicians recommend these options when the expected benefits outweigh the risks and when a patient’s lifestyle or adherence challenges make medical therapy less effective.

Traditional filtering surgeries are generally reserved for advanced disease or eyes that have not responded to less invasive measures, as they tend to provide greater pressure reduction but carry higher risk and require close postoperative care. The decision to proceed is based on the rate of progression, target pressure needed to protect vision, and overall health. Shared decision-making helps patients understand the expected outcomes and postoperative requirements.

Monitoring frequency is individualized according to disease severity, risk factors and stability. Newly diagnosed patients or those with evidence of progression often need follow-up every three months until pressure and testing trends are stable, while stable, low-risk patients may be seen every six to twelve months for exams and testing. Each visit typically includes pressure checks, targeted imaging and periodic visual field testing to detect changes early.

Clinicians may shorten or lengthen intervals based on test results, rate of change and treatment changes. Patients should report new symptoms promptly between visits, as urgent changes may require immediate assessment. Consistent monitoring is the most effective way to identify progression when intervention can still preserve vision.

While no lifestyle change replaces medical or procedural therapy, general health measures support ocular circulation and overall well-being. Controlling systemic conditions such as diabetes and hypertension, avoiding tobacco, maintaining regular exercise and eating a balanced diet all contribute to vascular health that can indirectly benefit the optic nerve. Patients should discuss with their clinician any activities or positions that may transiently raise intraocular pressure, such as heavy weightlifting or inverted head positions.

Adherence to prescribed eye drops, using correct instillation technique and keeping an up-to-date list of medications and eye history are practical steps that directly influence outcomes. Patients should avoid unproven home remedies and always consult their eye doctor before starting supplements or new therapies. Open communication about side effects or barriers to adherence allows the care team to adjust the plan for better results.

Most chronic glaucomas cause gradual, painless loss of peripheral vision rather than sudden central vision loss. However, acute angle-closure glaucoma is an exception and can present with rapidly worsening vision, severe eye pain, redness, nausea, and halos around lights; this condition is an emergency that requires immediate treatment to prevent permanent damage. Recognizing the difference between gradual progression and an acute presentation is important for timely care.

Patients should seek urgent evaluation for sudden visual changes, severe eye pain, sudden nausea with eye symptoms, or any abrupt loss of vision. Prompt assessment and treatment can be sight-saving in acute cases and can limit irreversible optic nerve injury. If you experience these symptoms, contact your eye care provider or emergency services right away.

Treatment planning takes into account glaucoma subtype, intraocular pressure levels, optic nerve appearance, visual field status, age, life expectancy and comorbid conditions. The concept of a target pressure is used to set treatment goals that reduce the risk of future vision loss, and clinicians select therapies expected to achieve that target while minimizing side effects. Objective data from imaging and visual fields, along with trend analysis over time, guide whether to escalate, maintain or reduce treatment.

Patient preferences, daily routines and ability to adhere to medication schedules are also central to decision-making, as successful long-term management depends on sustained adherence and follow-up. Shared decision-making ensures that the chosen plan aligns with the patient’s priorities and practical realities. Regular reassessment allows clinicians to adapt therapy if progression occurs or circumstances change.

To schedule a glaucoma evaluation, call (404) 662-4123 or contact our Alpharetta office at 6365 Halcyon Way, Suite 935, Alpharetta, GA 30005 to request an appointment. A comprehensive medical-focused eye exam for glaucoma typically includes pressure measurements, imaging (such as OCT), visual field testing and an optic nerve assessment, which may require additional time compared with a routine vision check. Bringing a current list of medications and any prior eye records or imaging helps ensure a complete assessment.

During your visit the clinician will review risk factors, perform baseline testing and discuss follow-up intervals and treatment options if needed. If you use eye drops, bring them to the appointment and be prepared to describe how you use them to help the care team evaluate effectiveness and adherence. Early evaluation and baseline testing give the practice the best chance to detect disease and tailor a long-term monitoring plan.